Insulin Resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression

Transplantation

Volumn 89, Issue 3, 2010, Pages 327-333

  Sharif, Adnan ^a   Ravindran, Vinod ^b   Moore, Richard H ^b   Dunseath, Gareth ^c   Luzio, Steve ^c   Owens, David R ^c   Baboolal, Keshwar ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Insulin resistance; Metabolic syndrome; New onset diabetes after transplantation; Tacrolimus

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SENSITIVITY CHECK INDEX; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MCAULEY INDEX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULSE PRESSURE; WAIST HIP RATIO;

DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT SELECTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; TACROLIMUS; WALES;

EID: 76649139481     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bbf2c4     Document Type: Article

References (31)

1. Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation-How much of the promise has been realized? Nat Med 2005; 11: 605.
2. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
3. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
4. Cosio FG, Kudva Y, Velde MVD, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415.
5. Porrini E, Delgado P, Bigo C, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134.
6. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, et al. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53: 563.
7. Balkau B, Valensi P, Eschwege E, Slama G. A review of the metabolic syndrome. Diabetes Metab 2007; 33: 405.
8. Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophys-iology: The role of adipose tissue. Nutr Metab Cardiovasc Dis 2007; 17: 125.
9. Oterdoom LH, de Vries AP, van Son WJ, et al. Validation of insulin resistance indexesin astable renal transplant population. Diabetes Care 2005; 28: 2424.
10. Hjelmesaeth J, Midtvedt K, Jenssen T, et al. Insulin resistance after renal transplantation: Impact of immunosuppressive and antihyper-tensive therapy. Diabetes Care 2001; 24: 2121.
11. de Vries AP, Bakker SJ. Insulin resistance after renal transplantation. Diabetes Care 2002; 25: 1259; author reply 1260.
12. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
13. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506.
14. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance: Minimal-model approach. Diabetes 1989; 38: 1512.
15. Crigger BJ. Declaration of Helsinki revised. IRB 2000; 22: 10.
16. Sharif A, Ravindran V, Moore R, et al. The effect of Rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients. Am J Transplant 2009; 9: 1439.
17. Ravindran VK, Moore RH, Dunseath G, et al. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. Transplantation 2009; 87: 1870.
18. Bergman RN, Prager R, Volund A, et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987; 79: 790.
19. Steil GM, Murray J, Bergman RN, et al. Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Implications for study design. Diabetes 1994; 43: 1365.
20. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469.
21. Midtvedt K, Hartmann A, Hjelmesaeth J, et al. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998; 13: 427.
22. Ferrara CM, Goldberg AP. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 2001; 24: 245.
23. Manetta J, Brun JF, Mercier J, et al. The effects of exercise training intensification on glucose disposal in elite cyclists. Int J Sports Med 2000; 21: 338.
24. Brandou F, Brun JF, Mercier J. Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 2005; 90: 761.
25. Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation 2008; 85: 353.
26. Hoban R, Gielda B, Temkit M, et al. Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation 2006; 81: 379.
27. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictorof risk for the developmentofdiabetesin the West of Scotland Coronary Prevention Study. Diabetes 2002; 51: 1596.
28. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888.
29. Gale EA. Should we dump the metabolic syndrome? Yes. BMJ 2008; 336: 640.
30. Alberti KG, Zimmet PZ. Should we dump the metabolic syndrome? No. BMJ 2008; 336: 641.
31. Sharif A. Insulin, glucose, and glomerular filtration rate. Transplantation 2009; 87: 1592.